引用本文:汤 玲 王冬梅 顾慧霞 刘 丽 王燕霞 贺稚平.肌瘤内消丸治疗子宫肌瘤临床疗效分析[J].世界中医药,2012,7(5):. |
|
肌瘤内消丸治疗子宫肌瘤临床疗效分析 |
Clinical Theraputic Effect of Zhongliu Neixao Pill on Uterine Fibroids |
投稿时间:2011-12-13 |
DOI: |
中文关键词: 子宫肌瘤 肌瘤内消丸 气虚血瘀 |
English Keywords:Uterine fibroids Zhongliu Neixao Pill Qi deficiency and blood stasis |
基金项目:北京中医药大学中青年教师资助项目(编号:JYB22-JS064) |
|
摘要点击次数: 1337 |
全文下载次数: 1183 |
中文摘要: |
目的:观察肌瘤内消丸治疗子宫肌瘤临床疗效。方法:将60例确诊为子宫肌瘤的患者随机分为2组,治疗组30例和对照组30例。治疗组给予肌瘤内消丸治疗,对照组给予米非司酮,疗程均为3个月。3个月后对比疗效。结果:治疗组患者总有效率86.67%,对照组患者治疗总有效率63.33%,两者比较有统计学意义,P<0.05。结论:肌瘤内消丸治疗子宫肌瘤临床效果显著,值得临床推广。 |
English Summary: |
To observe clinical theraputic effect of Zhongliu Neixao Pill on uterine fibroids.Methods: Sixty patients diagnosed with uterine fibroids were randomly divided into 2 groups: the treatment group (30 cases)and the control group (30 cases).The treatment group received Zhongliuneixaowan,and the control group received mifepristone.The clinical effect was compared after 3 months clinical course.Results:The effect rate of Treatment group is 86.67%,and the control group is 63.33%.Conclusion:Clinical effect of Zhongliuneixaowan on Uterine fibroids is more significant than mifepristone desere the clinical expansion. |
查看全文 查看/发表评论 下载PDF阅读器 |